ArticleWorld journal of urology2020

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer.

Simon Kind et al.PubMed ↗Publisher ↗

No numbers read from the abstract.